SG Americas Securities, LLC
- SEC CIK
- 0001313360
- Latest filing
- Aug 7, 2026
XERS holding history
Xeris Biopharma Holdings, Inc. in every 13F filed by SG Americas Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
XERS overviewAll 13F holders of XERSFull Q2 2026 holdings
- Shares (Q2 2026)
- 13,713
- Value
- $109.0K
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 13,713 | $109.0K | <0.1% | −108,198−88.8% | Reduced | Holders |
| Q1 2026 | 121,911 | $707.0K | <0.1% | +11,731+10.6% | Added | Holders |
| Q4 2025 | 110,180 | $865.0K | <0.1% | +26,966+32.4% | Added | Holders |
| Q3 2025 | 83,214 | $677.0K | <0.1% | +63,921+331.3% | Added | Holders |
| Q2 2025 | 19,293 | $90.0K | <0.1% | −51,206−72.6% | Reduced | Holders |
| Q1 2025 | 70,499 | $387.0K | <0.1% | −24,172−25.5% | Reduced | Holders |
| Q4 2024 | 94,671 | $321.0K | <0.1% | +34,469+57.3% | Added | Holders |
| Q3 2024 | 60,202 | $172.0K | <0.1% | +39,335+188.5% | Added | Holders |
| Q2 2024 | 20,867 | $47.0K | <0.1% | −150−0.7% | Reduced | Holders |
| Q1 2024 | 21,017 | $46.0K | <0.1% | −12,760−37.8% | Reduced | Holders |
| Q4 2023 | 33,777 | $79.0K | <0.1% | +15,414+83.9% | Added | Holders |
| Q3 2023 | 18,363 | $34.0K | <0.1% | +18,363 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −40,947−100.0% | Sold out | Holders |
| Q1 2023 | 40,947 | $67.0K | <0.1% | +40,947 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −25,397−100.0% | Sold out | Holders |
| Q3 2022 | 25,397 | $40.0K | <0.1% | +25,397 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −244,228−100.0% | Sold out | Holders |
| Q2 2021 | 244,228 | $994.0K | <0.1% | +244,228 | New | Holders |